Vireo Growth (VREOF) Common Equity (2020 - 2026)

Vireo Growth (VREOF) reported Common Equity of $294.1 million for Q1 2026, up 482.38% on a YoY basis from $50.5 million in Q1 2025, and down 4.33% sequentially from $307.4 million in Q4 2025.

Vireo Growth (VREOF) Common Equity (2020 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 7 years of Common Equity data on file, last reported at $294.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Common Equity rose 482.38% year-over-year to $294.1 million; the trailing twelve-month figure through Mar 2026 stood at $294.1 million (up 482.38% YoY), and the FY2025 full-year result was $307.4 million, up 452.88% from the prior year.
  • Common Equity declined to $294.1 million in Q1 2026, from $307.4 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $307.4 million in Q4 2025 to a low of -$22.6 million in Q1 2024.
  • A 5-year average of $70.6 million and a median of $16.5 million in 2022 frame the typical range for Common Equity.
  • Across the five-year window, Common Equity tumbled 991.83% in 2024 and surged 2338.48% in 2025, its largest moves.
  • Tracing VREOF's Common Equity over 5 years: stood at $3.4 million in 2022, then sank by 566.27% to -$16.0 million in 2023, then surged by 446.55% to $55.6 million in 2024, then soared by 452.88% to $307.4 million in 2025, then retreated by 4.33% to $294.1 million in 2026.
  • Business Quant data shows VREOF's Common Equity at $294.1 million in Q1 2026, $307.4 million in Q4 2025, and $246.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 21.93 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 8.23 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 3.23 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 47.38 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 5.90 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 56.13 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 14.66 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 3.41 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.50 Bn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 294.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 294.10 Mn
Dec 31, 2025 307.40 Mn
Sep 30, 2025 246.31 Mn
Jun 30, 2025 268.58 Mn
Mar 31, 2025 50.50 Mn
Dec 31, 2024 55.60 Mn
Sep 30, 2024 -11.00 Mn
Jun 30, 2024 -22.56 Mn
Mar 31, 2024 -22.58 Mn
Dec 31, 2023 -16.04 Mn
Sep 30, 2023 -12.85 Mn
Jun 30, 2023 -7.92 Mn
Mar 31, 2023 -2.07 Mn
Dec 31, 2022 3.44 Mn
Sep 30, 2022 16.48 Mn
Jun 30, 2022 24.00 Mn
Mar 31, 2022 29.08 Mn
Dec 31, 2021 43.01 Mn
Sep 30, 2021 53.81 Mn
Jun 30, 2021 59.77 Mn